This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Kronos Worldwide's (KRO) Q3 Earnings and Sales Miss Estimates
by Zacks Equity Research
The decline in the bottom line of Kronos (KRO) is primarily due to lower sales volumes and average TiO2 selling prices in Q3.
Ingevity's (NGVT) Earnings and Sales Miss Estimates in Q3
by Zacks Equity Research
Lower volumes due to weak industrial demand hurt Ingevity's (NGVT) Advanced Polymer Technologies and the Industrial Specialties business lines in Q3.
Scotts Miracle-Gro (SMG) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
The decline in sales of Scotts Miracle-Gro (SMG) is due to lower sales in the U.S. Consumer and Hawthorne segments in Q4.
Huntsman's (HUN) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Huntsman's (HUN) revenues decline in Q3 owing to lower average selling price, low sales volume and adverse sales mix.
Olin (OLN) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
The top line of Olin (OLN) is hurt by lower volumes in its chemical businesses in Q3.
LyondellBasell's (LYB) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
Strong oxyfuels margins contribute to record EBITDA in LyondellBasell's (LYB) Intermediates & Derivatives segment in the third quarter.
Eastman Chemical (EMN) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Revenues of Eastman Chemical (EMN) decline in Q3 primarily due to lower sales volume and reduced selling prices.
Methanex's (MEOH) Earnings & Sales Surpass Estimates in Q3
by Zacks Equity Research
Production of Methanex (MEOH) in Q3 totals 1,545,000 tons, up around 23.4% year over year.
Agnico Eagle's (AEM) Q3 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Gold production at Agnico Eagle (AEM) increases year over year in Q3 due to production from the acquisition of the remaining 50% of the Canadian Malartic complex.
Sherwin-Williams (SHW) Beats on Q3 Earnings & Sales, Ups View
by Zacks Equity Research
The rise in sales of Sherwin-Williams (SHW) is primarily attributable to selling price increases in all segments in Q3.